SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doug Bean who wrote (1514)11/30/1999 6:32:00 PM
From: Richaaard  Read Replies (1) of 1837
 
I agree with much of what you say about the Cenestin 1.25 press release, but if the company throws in a tidbit about Apri sales or other news your thinking goes out the window. I believe the company will take the opportunity to give us additional news and it could be of value. Keep in mind that Solvay bought at $9.00, and DRMD may want to do all they can to keep their buddies happy.

Day traders have been trying to latch onto anything lately, even the sublime. If day traders latch onto this, combined with a short squeeze, it could get interesting.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext